2.39
4.37%
0.10
Handel nachbörslich:
2.39
Schlusskurs vom Vortag:
$2.29
Offen:
$2.29
24-Stunden-Volumen:
46,359
Relative Volume:
0.62
Marktkapitalisierung:
$65.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.47M
KGV:
-1.5419
EPS:
-1.55
Netto-Cashflow:
$-12.19M
1W Leistung:
-0.83%
1M Leistung:
+5.29%
6M Leistung:
+15.46%
1J Leistung:
+83.85%
Heartbeam Inc Stock (BEAT) Company Profile
Firmenname
Heartbeam Inc
Sektor
Branche
Telefon
408-899-4443
Adresse
2118 WALSH AVE., SUITE 210, SANTA CLARA
Vergleichen Sie BEAT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
BEAT | 2.39 | 65.04M | 0 | -14.47M | -12.19M | -1.55 |
VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-09-11 | Eingeleitet | Needham | Buy |
2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
2020-01-08 | Eingeleitet | SunTrust | Buy |
2019-08-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-04-26 | Bestätigt | Dougherty & Company | Buy |
2018-07-26 | Bestätigt | Lake Street | Buy |
2018-04-26 | Bestätigt | The Benchmark Company | Buy |
2018-02-23 | Bestätigt | Dougherty & Company | Buy |
2017-11-08 | Bestätigt | Dougherty & Company | Buy |
2017-10-26 | Eingeleitet | Raymond James | Outperform |
2017-10-24 | Eingeleitet | SunTrust | Buy |
2017-08-09 | Bestätigt | Dougherty & Company | Buy |
2017-07-19 | Bestätigt | The Benchmark Company | Buy |
2017-04-11 | Bestätigt | Dougherty & Company | Buy |
2016-12-02 | Eingeleitet | Dougherty & Company | Buy |
2016-09-13 | Eingeleitet | Sidoti | Buy |
2016-08-03 | Bestätigt | The Benchmark Company | Buy |
2015-07-28 | Bestätigt | Dougherty & Company | Buy |
2013-10-24 | Eingeleitet | The Benchmark Company | Buy |
2013-08-21 | Eingeleitet | Dougherty & Company | Buy |
Alle ansehen
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer
HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks
HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan
HeartBeam Reports Third Quarter 2024 Results - Yahoo Finance
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tripp Investments Alters Stake in Betmakers - MSN
Severfield PLC Executes Share Buy-Back on LSE - MSN
HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
HeartBeam Appoints Robert Eno as New CEO - TipRanks
Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
Diamondback Energy (FANG) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR
HeartBeam names Robert Eno as new CEO for growth phase - Investing.com
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
HeartBeam Appoints Robert Eno as Chief Exec - MPO-mag
Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag
Dr. Lance Myers Joins HeartBeam as Chief AI Scientist - MPO-mag
Short Interest in HeartBeam, Inc. (NASDAQ:BEATW) Decreases By 17.6% - Defense World
HeartBeam appoints AI expert Lance Myers as Chief Scientist - Investing.com
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation - Simply Wall St
Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth? - Yahoo Finance
Timothy Cruickshank named HeartBeam CFO - Medical Buyer
Heartbeam stock retains Speculative Buy rating despite near-term risks - Investing.com India
HeartBeam Names Timothy Cruickshank As CFO - MPO-mag
HeartBeam Appoints New CFO to Bolster Financial Strategy - TipRanks
HeartBeam names new CFO to bolster financial strategy By Investing.com - Investing.com Canada
HeartBeam names new CFO to bolster financial strategy - Investing.com
HeartBeam Names Timothy Cruickshank as Chief Financial Officer - StockTitan
HeartBeam stock target unchanged as Benchmark reiterates Speculative Buy rating - Investing.com
Heartbeam director sells over $4,900 in company stock - Investing.com
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Up 115.4% in August - Defense World
Heartbeam executive sells shares worth over $6,400 - Investing.com
HeartBeam (NASDAQ: BEAT) Announces Positive Study Data For Its AI Program - Barchart
Branislav Vajdic - Forbes
The Globe and Mail - The Globe and Mail
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss - Investing.com
Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss By Investing.com - Investing.com UK
HeartBeam Reports Second Quarter 2024 Results - 01Net
BEATHeartBeam, Inc. Latest Stock News & Market Updates - StockTitan
HeartBeam, Inc. (NASDAQ:BEATW) Sees Large Drop in Short Interest - Defense World
HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time - Quantisnow
Finanzdaten der Heartbeam Inc-Aktie (BEAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):